About Tirzepatide

Tirzepatide is a dual incretin research peptide that targets both GLP-1 and GIP receptors — two complementary pathways involved in metabolic regulation, appetite signaling, and insulin sensitivity. Areas of Ongoing Research: • Supports appetite regulation and craving control via GLP-1 signaling • Slows gastric emptying to promote prolonged satiety • Enhances insulin sensitivity and glucose regulation • Activates GIP pathways involved in energy utilization • Supports preservation of lean muscle mass during fat reduction • Encourages efficient fat metabolism and metabolic balance.

Product Information